Navigation Links
MGC Diagnostics Corporation Announces Worldwide Exclusive Distribution Partnership with Restech Respiratory Technology
Date:3/19/2013

SAINT PAUL, Minn., March 19, 2013 /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD) (formerly Angeion Corporation), a global medical technology leader, today announced that it has entered into a worldwide distribution agreement with Restech Respiratory Technology (Restech Srl), a privately held company spun-off from the Politecnico di Milano, Italy, to  market and distribute the Resmon Pro, Forced Oscillation Technique (FOT) device. Manufactured by Restech Srl, the Resmon Pro aids in the diagnosis and treatment of respiratory disease. Typically, the diagnosis of common respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) involve complex measurements and maximum patient effort. Restech developed patented technology to determine the breath-by-breath presence and severity of expiratory flow limitation (EFL) during quiet breathing. Using the Resmon Pro, a physician can detect the presence, severity and reversibility of EFL, and evaluate the degree of airflow obstruction and shortness-of-breath experienced by the patient.

(Logo:  http://photos.prnewswire.com/prnh/20120821/LA60189LOGO)

Gregg O. Lehman , Ph.D., Chief Executive Officer and President of MGC Diagnostics, commented "Our agreement with Restech is an example of how MGC Diagnostics will execute strategic partnerships with emerging technology providers, both within the university sciences and entrepreneurial start-up sectors. Leveraging MGC Diagnostics global sales, marketing, and support network provides emerging technology companies best-in-class access to cardiorespiratory healthcare professionals and their patients throughout the world."

About Restech Respiratory TechnologyRestech SRL is a spinoff company of Politecnico di Milano derived from a Bioengineering Department research team of the Biomedical Technology Laboratory (TBMLab). Their primary focus is in the development of innovative products and services for the diagnosis, monitoring and management of patients affected by respiratory diseases.

About MGC DiagnosticsMGC Diagnostics Corporation, (formerly Angeion Corporation) through its subsidiary Medical Graphics Corporation, is a global medical technology company dedicated to cardiorespiratory health solutions. MGC Diagnostics develops, manufactures and markets non-invasive diagnostic systems. This portfolio of products provides solutions for disease detection, integrated care, and wellness across the spectrum of cardiorespiratory healthcare. The Company's products are sold internationally through distributors and in the United States through a direct sales force targeting heart and lung specialists located in hospitals, university-based medical centers, medical clinics, physicians' offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations (CROs). For more information about MGC Diagnostics, visit www.mgcdiagnostics.com.

Cautionary Statement Regarding Forward Looking StatementsFrom time to time, in reports filed with the Securities and Exchange Commission, in press releases, and in other communications to shareholders or the investing public, MGC Diagnostics Corporation may make forward−looking statements concerning possible or anticipated future financial performance, business activities or plans that include the words "believes," "expects," "anticipates," "intends" or similar expressions. For these forward−looking statements, the Company claims the protection of the safe harbor for forward−looking statements contained in federal securities laws. These forward−looking statements are subject to a number of factors, risks and uncertainties, including those disclosed in our periodic filings with the SEC, that could cause actual performance, activities or plans after the date the statements are made to differ significantly from those indicated in the forward−looking statements. For a list of these factors¸ see the sections entitled "Risk Factors" and "Cautionary Note Regarding Forward Looking Statements," in the Company's Form 10-K for the year ended October 31, 2012, and any updates in subsequent filings on Form 10-Q or Form 8-K under the Securities Exchange Act of 1934.Contact:

Gregg O. Lehman, Ph.D.Joe Dorame, Robert Blum, Joe DiazMGC Diagnostics Corporation

Lytham Partners, LLCChief Executive Officer

(602) 889-9700(651) 484-4874mgcd@lythampartners.com


'/>"/>
SOURCE MGC Diagnostics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Athena Diagnostics Announces New Genetic Testing Services for Rare Neurological Disorders
2. Quest Diagnostics Launches Dementia Diagnostic Panel, First in Industry for Treatable Forms of Cognitive Impairment Based on Medical Guidelines
3. Ariosa Diagnostics Introduces Y-Chromosome Analysis Test Option
4. PET/MR Scanner Holds Promise For Expanded Diagnostics
5. In Vitro Diagnostics Markets Grow at Double the Pace of Pharma Markets in Shift toward Globalization
6. MGC Diagnostics Corporation Reports 2013 First Fiscal Quarter Operating Results
7. MD Buylines User Satisfaction Report Awards MGC Diagnostics Pulmonary Function Products Top Rating for Fourth Consecutive Quarter
8. MGC Diagnostics Corporation Announces Partnership with Frontera Strategies, LP
9. MGC Diagnostics Corporation to Report First Quarter Fiscal 2013 Financial Results on Tuesday, March 5, 2013
10. Quest Diagnostics to Sell HemoCue Business to Radiometer Medical ApS
11. Quest Diagnostics to Provide Nationwide Access to Nateras New Non-Invasive Prenatal Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/22/2017)... Md. , Sept. 22, 2017  As the ... Republican Senators Bill Cassidy (R-LA) and ... Information notes that the medical device industry is in ... medical device tax, the 2.3% excise tax on medical ... But they also want covered patients, increased visits and ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
Breaking Medicine Technology:
(Date:9/24/2017)... ... 24, 2017 , ... The Tuscany Resort on Grace Bay in the Turks ... boutique resorts, is planning on re-opening the resort on October 1st. , ... more recently Hurricane Maria, and the staff and landscaping crews were fast in the ...
(Date:9/24/2017)... ... ... The Bible: The Other Sheep”: the ceremonial laws of Moses and the Holy Law of ... of published author, Maurice Caines. Maurice Caines resides in the sunny isle of Florida, ... the Seventh-day Adventist Church for many years. He was previously a member of the ...
(Date:9/22/2017)... ... ... On Sunday, September 24, hundreds will gather at Flo Jo Park for ... fastest woman of all time. Flo Jo passed away from complications related to ... Anthem. Mary was a contestant on the 2012 season of America’s Got Talent. ...
(Date:9/22/2017)... West Chester, PA (PRWEB) , ... September 22, ... ... and toddler sleep consulting firm in Pennsylvania, is pleased to offer in-home and ... ever, the effect that sleep deprivation has on the body,” says company owner ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... nutritional supplement produced by Native Remedies that helps promote pancreatic health and ... many individuals. However, some prescription-based approaches can have negative side effects, and with ...
Breaking Medicine News(10 mins):